The Missing Science panel: Prof Paul Long, Dr Louise Perkins, Dr Deborah Spencer and Elena Cardellini on women's bodies in pregnancy and postpartum

The Missing Science: Women's Bodies in Pregnancy and Postpartum

We know remarkably little about the skin of the vulva and perineum, compared with almost any other part of the body. Yet this is the skin that carries women through pregnancy, birth and recovery.

On 12 November 2026, BiotaLife brought together a scientist, a consultant midwife and a health innovation leader to ask why this gap exists, what it means for women, and what needs to change.

In this conversation

  • What science knows, and doesn't, about intimate skin
  • Why women are not listened to, and who is affected most
  • How pregnancy changes intimate skin, and why pH matters
  • Why "minor" complaints of pregnancy aren't minor for women
  • What "microbiome-friendly" really means
  • Perineal tears and antenatal perineal massage
  • The recovery nobody prepares you for
  • What needs to change in research and maternity care
  • Where femtech helps, and where it over-promises

Use the chapters in the video to jump straight to any topic.

What we heard

"I would like to see external intimate skin receive the same serious research attention as other parts of the body."
Prof Paul Long, King's College London

"The biggest thing that makes a difference is being known by your midwife."
Dr Louise Perkins, Consultant Midwife

"To all the researchers out there: we do need to do more on this."
Dr Deborah Spencer, ARC West London

The panel

Prof Paul Long is Professor of Pharmacognosy and Microbiology at King's College London, and Chief Technology Officer and co-founder of BiotaLife. He brings more than 35 years of research and industry experience across life sciences and pharma.

Dr Louise Perkins has been a consultant midwife in the NHS for 10 years. She has a specialist interest in values-based practice and in how women and clinicians perceive risk and safety. Her doctoral research focused on fear of birth.

Dr Deborah Spencer, moderator, is HealthTech Cluster Lead at ARC West London, where she leads strategic partnerships with Imperial College Healthcare NHS Trust and Imperial College. She previously spent almost seven years at the University of Oxford in senior innovation and partnership roles.

Elena Cardellini, host, is Chief Commercial Officer at BiotaLife.

Read the full transcript

Show transcript (lightly edited for readability)

Elena Cardellini: Good afternoon, everyone, and good morning to those joining from the other side of the globe. Welcome to The Missing Science, and thank you for spending your lunch break with us. I'll start with a bit of housekeeping while a few people are still joining. Just a reminder that the session is being recorded, and everyone who registered will receive the replay. Your microphone and camera will stay muted and off during the talk, but we would love to hear from you, so if you have any questions, please add them to the chat, and at the end we'll try to answer as many as we can. Now, let me start by introducing myself. I'm Elena Cardellini, Chief Commercial Officer at BiotaLife, and I'd like to start with something quite personal. When I gave birth, nobody told me half of what it would be like. No one really prepared me for the stretching, the stinging, and the recovery that came afterwards. I found out the hard way, like so many women do. Ever since, I've been the friend who tells pregnant women the truth, without any sugarcoating. When I went back to study for my Executive MBA a couple of years ago, I did it to pivot the second part of my career into something meaningful. I wanted something that wasn't just about bringing a product to market, but about real solutions to needs that women have never really been helped with. They've been left alone, to be honest. That's what brought me to BiotaLife. BiotaLife is an academic-led, university-independent spinout. Our work is grounded in an academic partnership between King's College London and UCL. Our mission is simple: to develop science-based, microbiome-friendly solutions for women, and to educate, because women's health has been overlooked and underfunded for far too long. The numbers tell the story. Only about 2% of UK public research funding goes to reproductive health and childbirth. And when the government asked women about their experience of care, 84% said there had been times when they were not listened to. That's the missing science we're here to talk about today. This month, we launched BloomCalma, our first product, designed for perineal massage before birth and skin recovery after. But today isn't about a product. It's about the conversation that should come first, the one most women never get to have. This is the first in a series of BiotaLife panels, and I'm very proud to be joined by our speakers. First, my colleague Professor Paul Long. He's Professor of Pharmacognosy and Microbiology at King's College London, and our Chief Technology Officer. He brings more than 35 years of research and industry experience across life sciences and pharma, with a PhD in microbiology. Paul is the scientist behind BloomCalma, and he helped us understand what really happens to the body and the microbiome through pregnancy. We also have Dr Louise Perkins, who has been a consultant midwife in the NHS for 10 years. She has a specialist interest in values-based practice, and in how women and clinicians perceive risk and safety. Her doctoral research focused on fear of birth. Louise brings the view from the front line of maternity care. And leading our conversation today is Dr Deborah Spencer, HealthTech Cluster Lead at ARC West London, a new science and innovation campus. Deborah leads strategic partnerships shared with Imperial College Healthcare NHS Trust and Imperial College, and is passionate about growing a women's health cluster. Before that, she spent almost seven years at the University of Oxford in senior innovation and partnership roles. Paul, Louise, Deborah, thank you for being here. Deborah, over to you.

Dr Deborah Spencer: Hello, everyone. Thank you for joining us today, and thanks, Elena, for that brilliant introduction to why we're here. Only 2% of research funding. So, I'm going to start by asking our panellists: why does this topic matter to you, personally or professionally? We've heard a little from Elena. Paul, would you like to kick off? Why does it matter to you?

Prof Paul Long: Thank you very much, everybody, for joining us today. As Elena said, I'm a microbiologist by training at King's College London, and also CTO and co-founder of BiotaLife. My interest is in how intimate tissues and the microbes that live on them interact with each other, and how we can bring better evidence to the products women use on these intimate areas during pregnancy and the time after birth, the fourth trimester. When I started looking into this area, I found a really striking gap in how much we know about, for example, the skin of the forearm compared with the skin in intimate areas. We use 'skin' as a catch-all term. Skin is skin, right? But it's not. Skin in different parts of the body is actually very different. We know a lot about the bugs that live on the skin of the forearm and in the vagina, but we know virtually nothing about the bugs that live on the vulva and the perineum. These are very different tissues, with their own local environments, so I'm really keen to understand how the balance between healthy skin, healthy living and a healthy pregnancy is mediated by the bugs involved.

Dr Deborah Spencer: Thank you, Paul. Louise, the same question: why does this topic matter to you?

Dr Louise Perkins: As a consultant midwife, I see women in my clinics, and I lead clinical services that look at what really matters to women and how we can best serve their needs around birth. What I see a lot is us as clinicians trying to inform and counsel women where the evidence is still lacking. I talk with women every week about what it means to promote a healthy microbiome, the impacts of different modes of birth, and the impact on the newborn's lifelong health depending on how women give birth. And where I'm challenged daily is that our knowledge feels like it's only at the beginning. What we need as clinicians is more robust evidence, to inform women's choices and support how they think about how amazing their bodies are at giving birth, the things we can proactively do to support physiological processes where that's what women want, or enough evidence to say, actually, where can we help optimise physiology to help women achieve the birth outcomes, and the healthy start for their babies, that they so want?

Dr Deborah Spencer: Thank you, Louise. I'm going to delve a little more into this. Paul, when you started researching intimate skin in pregnancy, what did you find, or not find, in the existing science? I know you've touched on it, but could you tell us a bit more?

Prof Paul Long: Very little research has been done on intimate skin at all. What I would like to see is external intimate skin taken seriously in research. Real, serious questions about what happens to the skin, its physiological changes during pregnancy, and what happens to the microbiome. And I think women really deserve to know what's happening to them. They need to be told in a way they understand, so they can make informed decisions about the products being pushed in their direction. I think that's really important.

Dr Deborah Spencer: Have you looked at this on a global scale, since we have international audiences joining us today? Are there any pockets around the world doing this, or is there just nothing?

Prof Paul Long: It's virtually nothing. This whole area of how the microbiome matters in health and disease has really taken off in recent years, but that's mostly to do with gut health, and how microbes in the gut can influence our health and disease in quite extraordinary ways, for example what's called the gut-brain axis: how microbes in the gut can affect your mental state, and perhaps long-term conditions like dementia, metabolic health and skin health. But when it comes to the microbiome during pregnancy, we don't know very much beyond what happens in the vagina and vaginal health, which we know quite a lot about. We know an awful lot about how the vaginal microbiome changes during pregnancy, and in fact across a woman's life course. But about what happens on the external intimate tissue, we know virtually nothing at all. I'm really keen on this area. When we think about the choices women make about how they give birth, I think it's important to consider. You also mentioned what's happening in other parts of the world. We really have to pay attention to the fact that not all women are the same. Everyone's microbiome is slightly different, and that's not just about geography. There's also a racial component, an ethnic component, genetic components. There are lots of things to consider. How the microbiome varies between women is an area wide open for research, and it's really neglected, because it has a huge impact on reproductive health. As I said earlier, my goal is a successful birth. Live births are what we want. And so often, where we see changes in the microbiome, what's called dysbiosis, this can lead to quite tragic birth outcomes.

Dr Deborah Spencer: Thank you, that's interesting. Louise, let me come to you. Where do you see the gap in clinic? What do women most often come to you with that nobody prepared them for? I think you've touched on that, and Elena has too.

Dr Louise Perkins: I counsel a lot of women about their options for how they give birth, whether they plan a vaginal birth or a caesarean birth, and the impact that has on the newborn's exposure to microbes and on the newborn microbiome. And I think there's so much in pregnancy and birth that is out of women's control. So, anything we can offer as midwives that's an evidence-based way of saying, 'You may be able to make a difference to your wish to avoid having an episiotomy during labour,' which is a cut to the perineum. Women want to be able to do things that actively help reduce their chances of that. Our job as midwives is to say: this is what the evidence says, for you and your individual circumstances, your background, your health profile, and to individualise that as much as we can, to give women information and things to take home and do. That's why, as midwives, we fairly routinely talk about antenatal perineal massage in pregnancy. But we are at the tip of the iceberg in terms of what we know about it. Are there any negative impacts of perineal massage? Are we sure the way women receive that information is culturally appropriate? How can we equip women to do it at home in a way that feels easy and straightforward, not intimidating or uncertain? There's a lot to be done in the area of education, and particularly in equity of access to that information.

Dr Deborah Spencer: Thank you, that's really interesting. A follow-up question: how does not being listened to, which we've heard about from Elena as well, show up for the women you care for? And are some women affected more than others? Could you explain a little about that?

Dr Louise Perkins: Yes, absolutely. Unfortunately, we know there is huge inequity in maternity outcomes. Much of that is on the macro scale of social deprivation and social inequality, which lead to inequity in health outcomes in pregnancy. But there are also the day-to-day barriers women experience as they go through maternity services. Anyone who's used the NHS knows it's hugely complex. You need a lot of cultural capital to know how to access it, from confusing hospital buildings to the confusing myriad of technologies we use to communicate with women. Those barriers just build up and build up. And the healthcare system isn't just complex for those accessing it, it's complex for those delivering it. Human nature, when you're working within complex systems, is to try to boil things down to the average woman's experience in a given situation. It's the heart of triage. It's what they do in emergency departments all the time, and what we do as clinicians every day. But in doing that, we can lose the nub of the concerns women are bringing to us. It makes it very easy not to hear women when you're working with lots of competing pressures.

Dr Deborah Spencer: So, bottom line, do you think the NHS is doing something about listening to these women? We've heard a lot in the media over the last couple of years about inequalities and women not being listened to, and it's a really big deal.

Dr Louise Perkins: I think, actually, the NHS and maternity services are a reflection of culture more generally. We know that women, whether they're pregnant, accessing menopause services, or experiencing pain as teenagers with the onset of menstruation, are just not listened to. It's not unique to maternity services. This is a wider cultural problem of embedded misogyny. Maternity services is one of those areas where we should be better, and there's so much work going on to be better. But we're swimming in the same fishbowl as all the other women who access services and find themselves not listened to, for various reasons, throughout their lives.

Dr Deborah Spencer: Thank you for that. I'm going to move on now to what pregnancy does to the body. Paul, how do skin and intimate tissue change through pregnancy and after birth, and how does that change what women should put on them?

Prof Paul Long: Well, I think Louise is probably better placed to answer that than I am, but

Dr Deborah Spencer: She'll come next. She can answer it as well. What are your thoughts on that?

Prof Paul Long: Of course, it's a big physiological change that women go through, and it's hormonally regulated. These hormones change the anatomy and physiology of women in preparation for birth. Typically, the skin and muscles start to stretch, and this can cause drying, irritation and dryness of the skin. It also changes how the skin produces its secretions. The secretions that control normal skin barrier function can start to change too, perhaps increasing the risk of tearing during the birthing process. So what we're interested in is how we can help alleviate some of the signs and symptoms of the normal physiological changes women go through during the gestation period, the period leading up to the birth. What's critical here is the secretions that regulate what goes on at the surface. In simple terms, that would be the moisture of the skin. But there's also something called pH, which, in simple terms, is how acidic or alkaline the skin is. And this really affects the microorganisms that grow on the skin. It has a great impact on their numbers and their diversity, which in turn could affect the function of the skin itself. We've come to think of skin as one size fits all, but the pH is different in different parts of the body. In the vagina it's very acidic, around 3.5 to 4. The forearm is a little less acidic, around pH 5. But surprisingly, the vulva and perineum are more neutral, around pH 6. That's a big difference in pH across the skin, and it can vary between women, at different times in their lives, and during pregnancy too. Yet we still tell women, 'Just use aloe vera, or an oil, or an aqueous gel,' the same kinds of things you might use on other parts of your body, and it will be fine. But we have no evidence for that. And of course these oils, gels and creams have their own acidity or alkalinity, which will affect the skin and the microbes associated with it. And that can change. Very little research has been done on what happens to these formulations, the gels and creams, with repeated use on a specific tissue. It's called the buffering of the formulation. We'd like formulations to stay at the same pH, but they could change, having a big impact on the healthy microbiome.

Dr Deborah Spencer: Louise, does any of this resonate with you? How does skin change through pregnancy and birth, and what do you recommend? Does what Paul was talking about reflect what you actually do in your work?

Dr Louise Perkins: Yes. What comes home to me as I listen to Paul is that we just don't know a lot of these things, and that comes across in how we talk to women about it. I think there's huge variation and inconsistency in what midwives recommend, evidence-based or not. I think it reflects how little focus there is on positive preparation, on supporting the stretching of the perineum with perineal massage, in the conversations we have about preparing for birth. It's tricky, isn't it? Without the evidence, we have to recommend things that are clinically appropriate. And one of the things that is particularly distressing for women is that all the physiological changes of pregnancy lead to an increased chance of UTIs in pregnancy, and an increased chance of thrush or BV, things like that, but we don't understand why. Women come to us with what they consider minor complaints of pregnancy. But actually, they aren't minor for women. They're really distressing. And we know they increase the risk of complications such as preterm birth. But because we can't see the bigger picture with the evidence we have at the moment, it's really difficult to counsel women holistically on how we can support them.

Dr Deborah Spencer: We've been talking a lot about prevention across many different areas of life sciences and medicine. Is this something you, or the researchers, maybe Paul would know, are considering, something more preventative? When women come to speak to you, they're worried. It's a really important time of their lives. They probably ask you, 'How can I prevent this from happening?' It could be an area to explore. So, to all the researchers out there, we do need to do more on this. Louise, I have another question for you. How much do women understand about their pelvic floor before birth? When does the conversation usually start, and when should it start?

Dr Louise Perkins: It's a great question, because often by the time women have even booked with us at 10 to 12 weeks, they're already experiencing changes in their pelvic floor that are entirely hormonally mediated. It comes as a shock to women how early those changes happen. So I think starting those conversations with women really early is really important for us as midwives. What the research absolutely supports, and what I've seen in my 20 years of practice, is that women are hugely unfamiliar with their own bodies. There was a piece of work done maybe 10 years ago that asked women about the anatomy of their vulva, and a significant proportion believed they urinated through their vagina. There's such a lack of understanding, even among relatively well-educated women, about what their bodies do. And there's no time like pregnancy when women really need to understand how their bodies function, so they can best support that in their pregnancy.

Dr Deborah Spencer: Yes. I'm just thinking that sex education at school is maybe where this all starts, Louise. You're probably thinking the same, from what you've just said. Paul, I know you've talked about the microbiome and how it works, but why does it matter in pregnancy, and what does 'microbiome-friendly' actually mean? Tell us a bit about that.

Prof Paul Long: That's a really good question. What does microbiome-friendly actually mean? Well, it means different things for different women, because women are all different. What we do know is that the microorganisms always present in healthy women, in the vagina and on the external skin, are very important for maintaining healthy physiology. And we know that when there's an imbalance, women experience certain conditions. Good examples are vulvovaginal thrush and bacterial vaginosis. So when we think about microbiome-friendly products, these are products that won't disrupt the microorganisms normally found on a woman's intimate skin. Another reason maintaining a healthy microbiome matters during pregnancy is something Louise hinted at right at the beginning: the choices women make about how they give birth, whether through the vaginal canal, the birth canal, or by C-section. There's nothing wrong with a C-section, and a lot of the time it's life-saving. But of course, in a C-section, the baby isn't exposed to the microorganisms found in the birth canal and on the external intimate tissues. It's now well known that exposure to these organisms is important for the child's development, particularly the development of their immunity. They're called pioneer colonisers, to use the in-phrase. During a vaginal birth, the baby is exposed to them and ingests them, and they colonise the gastrointestinal tract, which stimulates the formation of the immune system. There's a lot of emerging evidence suggesting that if a child isn't exposed to these organisms, there may be health impacts later in life, particularly obesity, type 2 diabetes, things like that. There's no concrete proof that this will happen, but the evidence is certainly pushing us in that direction. And I really want to be clear: there's nothing wrong with a C-section if that's what you choose.

Dr Deborah Spencer: Thank you for that. That's really useful to understand. We're going to move on now to something different. Up to 9 in 10 first-time mothers have a tear, graze or episiotomy, and around 6 in 100 have a deeper, third- or fourth-degree tear. Louise, can I come to you? What does the evidence say about antenatal perineal massage, and why are so few women told about it?

Dr Louise Perkins: One of the challenges with antenatal perineal massage is that it's not a quick conversation. Our appointments with women as midwives are 15 minutes long. There's an ever-increasing list of tasks we have to do, so proactive preparation for birth falls lower and lower down the list as we focus on preventative safety measures. But what we know about the consequences later on is that, as Elena was saying, women feel ill-prepared for what they're likely to experience. And it's really difficult with tears, because so many factors go into a woman's overall risk of having a particular type of tear. What the Cochrane reviews say, the meta-analysis of all the data we have from randomised controlled trials, is that overall, antenatal perineal massage is beneficial. It's unlikely to reduce your chance of a first- or second-degree tear, which is a fairly superficial tear into the muscle, and it's unlikely to reduce your chance of a more significant tear, but it is likely to reduce your chance of having an episiotomy, which is a cut. That's really challenging, because an episiotomy isn't a straightforward indicator that your perineum hasn't stretched enough. There are lots of other indications for it. But there's something there, around a woman's confidence in her body, her relationship with her care provider at the time of birth, and all the other factors that come into play, such as the position of the baby, the size of the baby, the length of the woman's perineum, and how she's been supported through birth.

Dr Deborah Spencer: That's great. A follow-on question for you: what do you see in the weeks after birth, and what do women most wish they had known?

Dr Louise Perkins: I think women are often unprepared for the recovery from birth, whether that's a vaginal birth or a caesarean. There's something almost evolutionary in us that puts so much focus on the birth itself, and women really struggle to realise how much impact a new baby at home has, having a dependant who wakes you every couple of hours, day and night, for weeks and weeks. The intensity of that experience, together with the huge hormonal shifts and the shift in your identity, is very hard to prepare for. I think we can help by putting a lot of focus on preparation for birth itself, so that women can also think about the transition to motherhood, and how they'll cope with it while going through physical recovery. A lot of the time, the expectation, and we see it on social media, is that women should be back at the supermarket within a week of birth. I think we can learn a lot from how cultures around the world have different ways of nurturing and nourishing women as they recover in the weeks after birth.

Dr Deborah Spencer: Yes, we can learn from each other, with family structures being different right across the globe. It's interesting. Being prepared, and understanding what might happen, is absolutely what you're saying, so that you can prepare mentally as well as physically. Paul, when do women do perineal massage? What should they look for in what they use, and why does texture matter? Interesting question.

Prof Paul Long: Typically, and Louise will correct me if I'm wrong, it's towards the end of the third trimester that women are generally advised to start preparing the perineum.

Dr Louise Perkins: 34 weeks is generally when we would discuss it from.

Prof Paul Long: Yes. And different people are advised to use different things. This is one area where, if I could make a change, I would like to see more serious research involving pregnant women and people who've gone through birth, to find out exactly what their experiences have been, so they can make informed decisions about the products they want to use, because different people have different experiences, wants and desires. If you look at what's out there at the moment, the textures range, for want of a better word, from thick, heavy creams that some people might prefer, to things that are very, very oily. It's also to do with the massage itself. You want to apply the formulation in a nice, smooth motion over the perineum, and you want it to leave the skin feeling silky and soft, as if it's had an effect. The last thing you want is something that leaves a residue, something that will get onto your clothes and stain them, things like that.

Dr Deborah Spencer: Really fascinating. Let's move on to a more in-depth discussion about the microbiome and pH, and what intimate skin needs. Pregnancy changes the intimate microbiome, which becomes more stable and Lactobacillus-dominated, then shifts again after birth. Yeast infections are also more common in pregnancy. So, Paul, since I have you here: what is the intimate microbiome, and what happens to it through pregnancy and after birth?

Prof Paul Long: I think what you're alluding to there is the vaginal microbiome. Essentially, it's a mixture of different microorganisms, typically bacteria, that live in the vagina. The friendly ones are called lactobacilli, and they feed off sugar that's naturally produced by the woman and secreted by the vaginal cells. That acts as a food source for the lactobacilli, which turn it into acid. That makes the vagina more acidic, which prevents other organisms from growing and surviving there, because most microorganisms don't like acid. What happens in pregnancy, as you rightly said, is that things become more stable in terms of the types of microorganisms we find, and we tend to see a lot more lactobacilli. It's a numbers game. The more lactobacilli you have, the more acidic the conditions become, and then it becomes a double-edged sword. The acidity is no longer protective. It actually becomes counterproductive, because certain microorganisms love acidic environments, and these are yeasts, the bad guys that cause thrush. That's why we tend to see a lot more thrush in pregnancy.

Dr Deborah Spencer: Sticking with that, why does pH matter for the skin around the vulva and perineum, and what happens when everyday products don't respect it?

Prof Paul Long: pH matters for normal function. There are enzymes on the skin that modulate how the skin works, its normal physiology. And that depends on the amount of water, the moisture of the skin, which can influence how alkaline or acidic the skin becomes. When you put a formulation on the skin, the formulation itself, the cream or the oil, has its own pH. That can shift the pH of the skin. It can overwhelm the normal pH and shift it towards the pH of the formulation, particularly if you're using a cream or gel regularly. What I'm really interested in, as I said earlier, is that the pH of what you put on your skin might change. You might use something for perineal massage that starts off at a fairly neutral pH, but by the time you've finished, it might have changed and become more acidic.

Dr Deborah Spencer: Thank you, that's really interesting. Louise, how often do women come to you with irritation, thrush or discomfort after birth, and what do you advise them to avoid? Is that something you see?

Dr Louise Perkins: Thrush is quite unusual. It probably isn't picked up that often in the immediate postnatal period, because women are seen so frequently during pregnancy that we'll have identified it earlier. More women are concerned about making sure their perineal stitches, if they've had them, heal quickly, and what we usually suggest is rest, keeping the area clean and dry, and basic care messages like that.

Dr Deborah Spencer: Are you able to prescribe anything, even for the dryness? Is that something you do?

Dr Louise Perkins: Not something that we do.

Dr Deborah Spencer: Right, moving on: what needs to change, and for whom. Until 1993, US federally funded research did not have to include women or minorities. What can NHS teams do now so that every woman gets the same information and the same chance to be heard, Louise?

Dr Louise Perkins: I think it's about investment in women's health and investment in services. We know midwifery services have been underfunded for many decades. We're still many thousands of midwives short in the UK, and as the amount midwives are asked to do increases, it affects the time we have to properly build therapeutic relationships and rapport with women, so that they feel they can have conversations with us about things like antenatal perineal massage, which are really intimate things to talk about. That's where we need investment, in time, so we can have the relationships with women that we know are beneficial.

Dr Deborah Spencer: And if there was one thing you could change to give women the same chance to be heard, what could we do better? You're a practitioner, so you

Dr Louise Perkins: The evidence is really clear. The thing that makes the biggest difference to women's outcomes in pregnancy and birth, alongside living healthy lives and not living in deprivation, is being known by your midwife: having continuity through pregnancy, being able to pick up a conversation you had three appointments ago, because you feel known and trusted, and you have that therapeutic relationship. We know it, it's clear, but it requires more investment in women's healthcare and maternity services than we're currently seeing. So, yes: continuity of care.

Dr Deborah Spencer: I'm going to ask you both the same question. If you could change one thing, in research, in care, or in what women are told, what would it be? Paul, this might be one for you.

Prof Paul Long: For me?

Dr Deborah Spencer: Yes, go ahead.

Prof Paul Long: I would like to see external intimate skin receive the same serious research attention as other parts of the body, with pregnant and postpartum women included in appropriately designed studies, so we can get the right evidence to inform women and they can make informed decisions themselves. That's what I think is missing right now.

Dr Deborah Spencer: Louise, did you want to add anything to what you said earlier, anything on research?

Dr Louise Perkins: Absolutely. As Paul was saying, we need decent research focused on the needs of women in pregnancy, and we need midwives who have the time and skills to have those conversations based on evidence.

Dr Deborah Spencer: What about innovation and femtech: where can they help, and where do they risk over-promising? That might be one for you, Louise, and I'll ask Paul the same question.

Dr Louise Perkins: I think there's always a challenge with femtech, because the problems we have to solve in maternity are often partly created by the circumstances, situations and systems in which women give birth. There are no easy fixes. Every woman's experience of birth is so multifactorial that it's really hard to narrow it down to certain key interventions. So we have to walk a tightrope: absolutely investing in innovation where we can, but also remembering to invest in the things we know make birth better for women, like continuity and access to choice of place of birth.

Dr Deborah Spencer: Paul, what are your thoughts on where innovation and femtech can help, and where they risk over-promising?

Prof Paul Long: I see this from a business point of view now, with femtech. Let's face it, the people with the money want a return on it. They're not that interested in the science. What they want to know is: if I give you a certain amount of money, how much will I make, and when will I get it back? So in femtech, the questions being answered at the moment are the big problems, the ones that can lead to death and serious injury in women. The big problems, I would say, like menopause. That's where a lot of the money goes. In terms of leading causes of death, you start thinking about things like Group B Strep carriage, things like that. What's the leading cause of mortality in women? But where I think we over-promise is in what we can actually deliver. Right now there's a lot of hype about what femtech can deliver, because we're not getting the serious funding for serious, large-scale clinical trials that include all women. You could see this from a very, I don't know the right word, but a very first-world, white, European, Western viewpoint, which of course excludes a huge number of women, for example in sub-Saharan Africa. Going back to microbiome health, we know there's huge disparity between women from different ethnic backgrounds in how much vaginal thrush and BV they experience. So there's a risk of over-promising, because we may be targeting a very narrow group of women from certain socio-economic and ethnic backgrounds, and we need to expand that. In the UK, I think we can, because we live in very diverse environments, particularly in the big cities, so we can recruit the women to do it. But that leads back to what Louise has been saying: it's also about equity of communication. A lot of these issues are very culturally sensitive, so we need to think not just about the bench science, but about the psychology of how we approach women, the conversations we have, and how we have them.

Dr Deborah Spencer: That might come from the medical professions, and from training people like Louise and her team right across the UK. I really agree with you. I now work for ARC West London, and we work closely with Imperial, who run a lot of clinical trials, and the ethnic diversity right across London is fantastic. UCL, King's College London and Imperial are all in a great location to recruit diverse populations of women. So it's about that interaction between the medical professions, and that includes GP surgeries, which are starting to recruit patients for these trials on the clinical side. I think we have a great opportunity here to make a difference. At ARC West London, we already have three women's health companies that have started up, so everything you're saying about the business side resonates. These CEOs and founders are very passionate. They've set up on our campus because they want to make a difference in women's health. Many have had negative experiences themselves, to be honest. That's why they started their companies. So it's about finding the funding, and helping them find the right environments to accelerate those companies and develop products and innovations that can actually help women. That's my two cents on all of this. I think those are all the questions we have, so let's open it up to the wider audience, to see if you have some clever questions we haven't thought of, for Paul, Louise, Elena, or me.

Elena Cardellini: We're right on time, actually. I think we ran through the conversation really smoothly, so I really want to thank everyone who joined us live today, and everyone watching the recording later. For me, it was really refreshing to hear a conversation centred on women's health and how science can help address these needs. Paul, I'm really glad our audience got to experience your depth of knowledge on the microbiome. It's a buzzword, for sure, but still not well understood. Thank you for sharing your knowledge, for expressing the urgency of making this change, and the progress we need in research so it can reach the women who need it. And Louise, thank you for being there for women all these years, at such a particularly sensitive time of their lives. I loved your really candid description of life after birth, and how you envision the support women should have as they move into this next stage of their lives. As you said, it's a completely life-changing time. And Deborah, thank you for guiding us through some really complex and sensitive topics. You did a fantastic job of keeping us engaged. We're now out of time, but we will definitely follow your work with ARC West London. We hope to see many more of these conversations, because they're really needed. And as Louise put it, most of all it's a shift in culture that we need. I hope today sparked your curiosity. If you'd like to learn more, please visit our Journal at biotalife.com, where you can find some of Paul's research and the articles we've published, and discover BloomCalma too. Thank you.

Dr Deborah Spencer: Thank you. Thanks, everyone.

Prof Paul Long: Thank you.

Keep exploring

This was the first in our series of conversations on women's health. To go deeper, explore our Journal, with articles from our scientists and advisors, or read our guide to perineal massage.

BloomCalma, our pH-balanced intimate moisturising gel for pregnancy and postpartum, was developed from the research behind our patented DuoBalance technology. Discover BloomCalma.

This discussion is for general information only and does not replace advice from your midwife, GP or another healthcare professional. Views expressed are the panellists' own.

BiotaLife is an academic-led, university-independent spinout. Its work is grounded in an academic partnership between King's College London and UCL.

Back to blog